Brokerage Firm Rating on Patterson Companies (PDCO)

Patterson Companies (PDCO) : Zacks Investment Research ranks Patterson Companies (PDCO) as 3, which is a Hold recommendation. 2 research analysts consider that the stocks fundamentals point to a bright future, hence they rate the stock as a Strong Buy. A total of 4 analysts believe that the stock has a limited upside, hence they advise a Hold. The average broker rating of 6 research analysts is 2.33, which indicates as a Buy.

Patterson Companies (PDCO) : 5 Wall Street analysts covering Patterson Companies (PDCO) believe that the average level the stock could reach for the short term is $53.8. The maximum price target given is $65 and the minimum target for short term is around $48, hence the standard deviation is calculated at $6.76.


Company shares have received an average consensus rating of Hold for the current week Patterson Companies (NASDAQ:PDCO): During Thursdays trading session, Bulls were in full control of the stock right from the opening. The stock opened at $46.33 and $46.00 proved to be the low of the day. Continuous buying at higher levels pushed the stock towards an intraday high of $46.73. The buying momentum continued till the end and the stock did not give up its gains. It closed at $46.41, notching a gain of 0.76% for the day. The total traded volume was 596,139 . The stock had closed at $46.06 on the previous day.

In a related news, The Securities and Exchange Commission has divulged that Gugino Ann B, officer (Vice President & CFO) of Patterson Companies, Inc., had unloaded 750 shares at an average price of $48.86 in a transaction dated on May 31, 2016. The total value of the transaction was worth $36,645.

Patterson Companies, Inc. is a distributor serving the dental, veterinary and rehabilitation supply markets. The Company operates through three segments: dental supply, veterinary supply and rehabilitation supply. The Companys dental supply segment provides consumable products (including x-ray film, restorative materials, hand instruments and sterilization products); basic and advanced technology dental equipment; practice management and clinical software; patient education systems, and office forms and stationery. The Companys veterinary supply segment distributes veterinary supplies to companion-pet (dogs, cats and other common household pets), equine and large animal veterinarians and veterinary clinics, public and private institutions and shelters across the United States and in the United Kingdom. The rehabilitation supply segment distributes rehabilitation medical supplies and equipment.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.